These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 16622644)

  • 21. Systemic chemotherapy in the treatment of malignant melanoma.
    Lens MB; Eisen TG
    Expert Opin Pharmacother; 2003 Dec; 4(12):2205-11. PubMed ID: 14640919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemotherapy for advanced adrenal cancer: improvement from a molecular approach?
    Costa R; Wesolowski R; Raghavan D
    BJU Int; 2011 Nov; 108(10):1546-54. PubMed ID: 21883840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemotherapy with cyclophosphamide, vincristine and dacarbazine for malignant paraganglioma and pheochromocytoma: systematic review and meta-analysis.
    Niemeijer ND; Alblas G; van Hulsteijn LT; Dekkers OM; Corssmit EP
    Clin Endocrinol (Oxf); 2014 Nov; 81(5):642-51. PubMed ID: 25041164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The management of cutaneous metastases].
    Börgermann C; Vom Dorp F; Krege S; Rübben H
    Urologe A; 2007 Jan; 46(1):56-8. PubMed ID: 17205346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Local recurrence following radical cystectomy for bladder cancer. Diagnostic and therapeutic options].
    Simon J; Gschwend JE; Volkmer BG
    Urologe A; 2005 Apr; 44(4):375-81. PubMed ID: 15750678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Palliative therapy concepts for patients with urothelial cancer of the urinary bladder].
    Vom Dorp F; Börgermann C; Rübben H
    Urologe A; 2007 Jan; 46(1):54-5. PubMed ID: 17203266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Options in palliative therapy for penile cancer].
    Preis E; Jakse G
    Urologe A; 2007 Jan; 46(1):49-53. PubMed ID: 17203267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Chemotherapy of malignant adrenal gland tumors].
    Zielinski CC; Schernthaner G
    Acta Med Austriaca; 1988; 15(4):120-2. PubMed ID: 3213381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Therapeutic strategies in colorectal cancer].
    Flieger D; Keller R; Fischbach W
    Dtsch Med Wochenschr; 2003 Sep; 128(37):1902-7. PubMed ID: 12970825
    [No Abstract]   [Full Text] [Related]  

  • 30. Therapeutic management of advanced adrenocortical carcinoma: what do we know in 2011?
    Baudin E; Leboulleux S; Al Ghuzlan A; Chougnet C; Young J; Deandreis D; Dumont F; Dechamps F; Caramella C; Chanson P; Lanoy E; Borget I; Schlumberger M
    Horm Cancer; 2011 Dec; 2(6):363-71. PubMed ID: 22161625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Principles of drug therapy of malignant tumors: the role of malignant progression in the choice of effective drugs].
    Jeney A; Rosta A
    Orv Hetil; 1999 May; 140(22):1245-9. PubMed ID: 10377736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Early instillation in superficial bladder carcinoma. Current status].
    Langbein S; Häcker A; Badawi JK; Michel MS; Alken P
    Urologe A; 2004 Dec; 43(12):1531-6. PubMed ID: 15592710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Malignant pheochromocytoma: effective treatment with a combination of cyclophosphamide, vincristine, and dacarbazine.
    Averbuch SD; Steakley CS; Young RC; Gelmann EP; Goldstein DS; Stull R; Keiser HR
    Ann Intern Med; 1988 Aug; 109(4):267-73. PubMed ID: 3395037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful treatment of malignant pheochromocytoma with combination chemotherapy containing anthracycline.
    Nakane M; Takahashi S; Sekine I; Fukui I; Koizumi M; Kage K; Ito Y; Aiba K; Horikoshi N; Hatake K; Ishikawa Y; Ogata E
    Ann Oncol; 2003 Sep; 14(9):1449-51. PubMed ID: 12954587
    [No Abstract]   [Full Text] [Related]  

  • 35. Wanted: guidelines for "palliative" anti-cancer drug use.
    Kearsley JH
    Med J Aust; 1994 Jun; 160(11):723-5. PubMed ID: 7515460
    [No Abstract]   [Full Text] [Related]  

  • 36. Second-line chemotherapy in recurrent small cell lung cancer. Results from a crossover schedule after primary treatment with cisplatin and etoposide (EP-regimen) or cyclophosphamide, epirubicin, and vincristin (CEV-regimen).
    Sundstrøm S; Bremnes RM; Kaasa S; Aasebø U; Aamdal S;
    Lung Cancer; 2005 May; 48(2):251-61. PubMed ID: 15829326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Penile cancer--aftercare with results. How much is necessary?].
    Paul R; van Randenborgh H; Schöler S; May F; Hartung R
    Urologe A; 2005 Sep; 44(9):1031-6. PubMed ID: 16075197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative effects of chemotherapeutic agents on the growth and survival of human adrenal carcinoma cells in culture.
    Montoya M; Brown JW; Fishman LM
    Horm Metab Res; 2008 May; 40(5):302-5. PubMed ID: 18491247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Palliative and supportive treatment options in patients with advanced prostate cancer].
    Maurer T; Retz M; Gschwend JE
    Urologe A; 2007 Jan; 46(1):30-5. PubMed ID: 17211644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Multimodal treatment of colon cancer?].
    Fahlke J; Schmidt C; Tautenhahn J; Hribaschek A; Stübs P; Lippert H
    Zentralbl Chir; 2006 Apr; 131(2):126-33. PubMed ID: 16612779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.